Artelo Biosciences, Inc. (ARTL) income statement
ARTLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$1.45−0.05 (-3.33%)
Close on Nov 19, 2026Market cap $975.86KP/E –Yield –
Artelo Biosciences, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- -1625.1%
Financial strength
- Current ratio
- 3.00
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 288.5%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 0.20
- Dividend yield
- –
See a number that looks wrong?